11 studies found for:    "Papilledema"
Show Display Options
Download search resultsDownload the search results for:
"Papilledema" (11 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Suspended Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease
Conditions: Nervous System Malformations;   Arthropathy, Neurogenic;   Urticaria;   Papilledema
Intervention:
2 Recruiting Antiacne Medications Pseudotumor Cerebri
Condition: Optic Disc Swelling
Intervention: Other: Retinal nerve fibre layer measurement
3 Completed Assessment of Retinal Nerve Fibre Layer by Optical Coherence Tomography in Uveitis Patients With Papilloedema
Conditions: Uveitis;   Glaucoma
Intervention:
4 Active, not recruiting Ozurdex for Macular Edema Post Membrane Peeling
Conditions: Epiretinal Membrane;   Cellophane Maculopathy;   Macular Edema;   Retinal Edema
Interventions: Drug: Dexamethasone;   Drug: dexamethasone
5 Completed
Has Results
Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study
Condition: Diabetic Macular Edema
Intervention: Drug: Macugen® pegaptanib sodium
6 Recruiting Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery
Conditions: Cataract;   Retinal Edema;   Inflammation
Interventions: Drug: Prolensa (bromfenac 0.07%);   Drug: Ilevro (nepafenac 0.3%)
7 Unknown  A Single-Center Trial of High Frequency Pegaptanib for Rapid Restoration of VEGF Levels in Diabetic Retinal Edema
Condition: Diabetic Macular Edema
Intervention: Drug: Macugen (Pegaptanib Sodium)
8 Withdrawn Disc Edema in Patients With Chronic Kidney Disease
Condition: Chronic Kidney Disease
Intervention:
9 Completed Idiopathic Intracranial Hypertension Treatment Trial
Condition: Idiopathic Intracranial Hypertension
Interventions: Drug: Acetazolamide;   Drug: Placebo;   Behavioral: Formal weight loss counselling program
10 Recruiting Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension.
Condition: Idiopathic Intracranial Hypertension
Intervention: Drug: AZD4017
11 Recruiting Studies of the Natural History and Pathogenesis and Outcome of Neonatal Onset Multisystem Inflammatory Disease (NOMID/CAPS, DIRA, CRMO, Still s Disease, Behcet s Disease, and Other Undifferentiated Autoinflammatory Diseases)
Conditions: Urticaria;   Arthropathy;   Lymphadenopathy;   Nervous System Anomalies
Intervention:

Indicates status has not been verified in more than two years